case report | Q2782326 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1112229884 |
P356 | DOI | 10.1186/S12888-019-2055-1 |
P932 | PMC publication ID | 6381751 |
P698 | PubMed publication ID | 30782143 |
P50 | author | Andrea Galova | Q91720096 |
P2093 | author name string | Jules Desmeules | |
Marie Besson | |||
Patricia Berney | |||
Ioannis Sergentanis | |||
P2860 | cites work | Severe Relapsing Clozapine-Withdrawal Catatonia | Q36405646 |
Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. | Q37725116 | ||
Catatonia Secondary to Sudden Clozapine Withdrawal: A Case with Three Repeated Episodes and a Literature Review | Q37726344 | ||
From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics | Q37771644 | ||
The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development | Q38177824 | ||
Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report | Q40645743 | ||
Clozapine withdrawal effects and receptor profiles of typical and atypical neuroleptics | Q40952478 | ||
Clozapine in tardive dyskinesia | Q41370034 | ||
Clozapine withdrawal resulting in delirium with psychosis: a report of three cases | Q41536197 | ||
A Case of Risperidone Overdose in a 4-Year-Old Boy. | Q42408865 | ||
Extrapyramidal symptoms following accidental ingestion of risperidone in a child | Q42520678 | ||
Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case report | Q45189024 | ||
Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal | Q46872086 | ||
The Treatment of Clozapine-Withdrawal Delirium with Electroconvulsive Therapy. | Q47136916 | ||
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. | Q47621835 | ||
Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group. | Q51981197 | ||
Withdrawal from clozapine: the "rebound phenomenon". | Q51981895 | ||
Catatonia following abrupt stoppage of clozapine. | Q53964235 | ||
A model of anticholinergic activity of atypical antipsychotic medications | Q59739287 | ||
Cautions in the clozapine-to-risperidone switch | Q71115876 | ||
Anticholinergics to treat clozapine withdrawal | Q72152249 | ||
Clozapine-olanzapine: a potentially dangerous switch. A report of two cases | Q78100895 | ||
Managing clozapine discontinuation - acute and chronic maintenance strategies | Q85300920 | ||
Clozapine Discontinuation and Malignant Catatonia: A Case Report | Q88497353 | ||
Review of withdrawal catatonia: what does this reveal about clozapine? | Q90672919 | ||
Catatonia Due to Clozapine Withdrawal: A Case Report and Literature Review | Q91879159 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 73 | |
P577 | publication date | 2019-02-19 | |
P1433 | published in | BMC Psychiatry | Q15750257 |
P1476 | title | A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder | |
P478 | volume | 19 |
Q89804908 | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database |
Q96773916 | The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia |
Search more.